{"id":"W4386705352","doi":"10.1001/jamacardio.2023.2921","title":"Longer-Term Efficacy and Safety of Evinacumab in Patients With Refractory Hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"JAMA Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"Novo Nordisk; Kowa Company; Esperion Therapeutics; Regeneron Pharmaceuticals; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Refractory (planetary science); Term (time); Safety profile; Intensive care medicine; Internal medicine; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002063684,0.0005375138,0.001337865,0.0001581455,0.0003587566,0.0005421441,0.000352509,0.001139188,0.002313907],"category_scores_gemma":[0.001756996,0.00026875,0.0009248159,0.0001947249,0.0004879885,0.0007082458,0.0002290592,0.001412552,0.0003411654],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003073437,"about_ca_system_score_gemma":0.0005293664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002499555,"about_ca_topic_score_gemma":0.00075376,"domain_scores_codex":[0.9992713,0.0004460235,0.00006392103,0.00007864986,0.00005490635,0.00008506908],"domain_scores_gemma":[0.9986231,0.0004222445,0.0004546929,0.00008616503,0.00005883706,0.0003549706],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8837679,0.01777734,0.01770405,0.0005850692,0.001425649,0.0001452449,0.00007769505,0.0006642186,0.01256205,0.00007187639,0.0007076361,0.06451128],"study_design_scores_gemma":[0.4570088,0.4643314,0.07167872,0.00008037291,0.001136072,0.0003421223,0.00007661679,0.0009201155,0.002445066,0.0001002163,0.001847689,0.00003278671],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960556,0.002871229,0.0001140693,0.0001359686,0.00004762037,0.0002534415,0.00009818173,0.00001139663,0.0004123659],"genre_scores_gemma":[0.99726,0.0008125316,0.0003264303,0.000347241,0.0001689566,0.0004117769,0.0002038412,0.000002819974,0.0004664751],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002313907,"threshold_uncertainty_score":0.01091391,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0110122507098251,"score_gpt":0.2525470643555331,"score_spread":0.241534813645708,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}